Veradigm Inc. (NASDAQ:MDRX – Get Free Report) fell 4.5% during trading on Friday . The stock traded as low as $9.00 and last traded at $9.75. 30,741 shares traded hands during mid-day trading, a decline of 98% from the average session volume of 1,502,042 shares. The stock had previously closed at $10.21.
Analyst Ratings Changes
Separately, StockNews.com initiated coverage on shares of Veradigm in a research note on Wednesday. They set a “hold” rating for the company. Three analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $11.75.
View Our Latest Stock Analysis on MDRX
Veradigm Trading Down 2.1 %
Institutional Inflows and Outflows
An institutional investor recently bought a new position in Veradigm stock. Innealta Capital LLC bought a new stake in Veradigm Inc. (NASDAQ:MDRX – Free Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 3,974 shares of the software maker’s stock, valued at approximately $38,000.
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Read More
- Five stocks we like better than Veradigm
- Why Invest in 5G? How to Invest in 5G Stocks
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- What Is WallStreetBets and What Stocks Are They Targeting?
- Texas Instruments: The Old-School Tech Titan Still Delivering
- What Are the FAANG Stocks and Are They Good Investments?
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.